Niche insulin MDN offers GlucoStabilizer, an FDA-cleared insulin dosing system for IV infusions, presenting a sales opportunity with hospital pharmacies, ICU departments, and anesthesia/pacu teams seeking automation to reduce hypoglycemia and streamline dosing workflows.

ICU outcomes The ICUTracker Outcomes Reporting System positions MDN to partner with critical care units aiming to benchmark and improve patient outcomes, opening cross-sell opportunities with hospital analytics teams, quality improvement, and executive stakeholders.

Small but focused With a lean team and annual revenue in the low to mid millions, MDN is likely open to scalable, cost-effective partnerships, channel programs, or OEM/white-label collaborations to extend product reach without significant on-boarding overhead.

Tech stack fit MDN’s Microsoft-based stack (ASP.NET, Windows Server, IIS) suggests alignment with enterprise healthcare IT environments; target opportunities include integrations with EMR/EHR systems, healthcare IT vendors, and MSPs serving hospital networks.

Growth signals The dual product line targeting clinical workflows and outcomes analytics indicates potential for expansion into additional hospital units (e.g., intensive care, anesthesia, perioperative services) and recurring revenue through analytics services, updates, and compliance features.